Intervention Review

Single agent versus combination chemotherapy for metastatic breast cancer

  1. Sue Carrick1,*,
  2. Sharon Parker2,
  3. Charlene E Thornton3,
  4. Davina Ghersi2,
  5. John Simes4,
  6. Nicholas Wilcken5

Editorial Group: Cochrane Breast Cancer Group

Published Online: 15 APR 2009

Assessed as up-to-date: 11 NOV 2008

DOI: 10.1002/14651858.CD003372.pub3


How to Cite

Carrick S, Parker S, Thornton CE, Ghersi D, Simes J, Wilcken N. Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD003372. DOI: 10.1002/14651858.CD003372.pub3.

Author Information

  1. 1

    The National Breast Cancer Foundation, Research Strategy, Sydney, NSW, Australia

  2. 2

    NHMRC Clinical Trials Centre, The University of Sydney, Systematic Reviews and Healthcare Assessment, Camperdown, NSW, Australia

  3. 3

    The University of Sydney, Systematic Reviews and Healthcare Assessment, NHMRC Clinical Trials Centre, Camperdown, NSW, Australia

  4. 4

    The University of Sydney, NHMRC Clinical Trials Centre, Camperdown, NSW, Australia

  5. 5

    Westmead and Nepean Hospitals, Medical Oncology, Westmead, NSW, Australia

*Sue Carrick, Research Strategy, The National Breast Cancer Foundation, GPO Box 4126, Sydney, NSW, 2001, Australia. sue.carrick@nbcf.org.au.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 15 APR 2009

SEARCH

  1. Current Version

    Single agent versus combination chemotherapy for metastatic breast cancer

    Sue Carrick, Sharon Parker, Charlene E Thornton, Davina Ghersi, John Simes and Nicholas Wilcken

    Version of Record online: 15 APR 2009 | DOI: 10.1002/14651858.CD003372.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Single agent versus combination chemotherapy for metastatic breast cancer

    Sue Carrick, Sharon Parker, Charlene E Thornton, Davina Ghersi, John Simes and Nicholas Wilcken

    Version of Record online: 20 APR 2005 | DOI: 10.1002/14651858.CD003372.pub2

  2. Version 1

    Single agent vs combination chemotherapy for metastatic breast cancer

    D Ghersi, J Simes, IC Henderson, RL Basser, C Brunswick, R Fossati, A Liberati, F Nole, K Pritchard, M Stockler, M Tattersall and N Wilcken

    Version of Record online: 23 OCT 2001 | DOI: 10.1002/14651858.CD003372